We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$403M
AUM Growth
-$4.68M
(-1.1%)
Cap. Flow
-$2.76M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
28.94%
Holding
118
New
3
Increased
17
Reduced
54
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.56M |
| 2 |
Adobe
ADBE
|
+$1.61M |
| 3 |
Tesla
TSLA
|
+$422K |
| 4 |
Aflac
AFL
|
+$199K |
| 5 |
WEC Energy
WEC
|
+$194K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.52M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.09M |
| 3 |
Qorvo
QRVO
|
+$877K |
| 4 |
Abbott
ABT
|
+$388K |
| 5 |
JPMorgan Chase
JPM
|
+$326K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.02% |
| 2 | Consumer Staples | 11.95% |
| 3 | Healthcare | 11.84% |
| 4 | Financials | 10.61% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Global Tech ETF
IXN
$8.77B
| $272K | 0.07% |
3,600
| – | – |
|
102
iShares Russell 1000 Growth ETF
IWF
$127B
| $260K | 0.06% |
2,888
-200
| -6% | -$19.7K |
|
103
HP
HPQ
$26.1B
| $240K | 0.06% |
8,680
| – | – |
|
104
iShares Russell 1000 ETF
IWB
$49.8B
| $235K | 0.06% |
768
| – | – |
|
105
Nucor
NUE
$62.6B
| $232K | 0.06% |
1,936
| – | – |
|
106
Lowe's Companies
LOW
$123B
| $228K | 0.06% |
980
| – | – |
|
107
Yum China
YUMC
$16.3B
| $224K | 0.06% |
4,320
| – | – |
|
108
Boeing
BA
$190B
| $221K | 0.05% |
1,300
| – | – |
|
109
RTX Corp
RTX
$300B
| $221K | 0.05% |
1,670
-100
| -6% | -$12.7K |
|
110
Agilent Technologies
A
$39.9B
| $215K | 0.05% |
1,841
| – | – |
|
111
American Express
AXP
$236B
| $215K | 0.05% |
800
| – | – |
|
|
112
Aflac
AFL
$63.9B
| $209K | 0.05% |
+1,880
| New | +$199K |
|
113
General Dynamics
GD
$104B
| $209K | 0.05% |
770
| – | – |
|
|
114
WEC Energy
WEC
$35.3B
| $207K | 0.05% |
+1,902
| New | +$194K |
|
115
Clorox
CLX
$12.8B
| $202K | 0.05% |
1,375
| – | – |
|
116
Empire State Realty Series ES
ESBA
$1.32B
| $83K | 0.02% |
10,754
| – | – |
|
|
117
CVS Health
CVS
$126B
| – | – |
-33,908
| Closed | -$1.52M |
|
|
118
Qorvo
QRVO
$8.4B
| – | – |
-12,555
| Closed | -$877K |
|
Similar funds
SCV
TFP
AI
CMHI
RS
DS
CWAF
MMG
Boston Research & Management's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Research & Management held 118 positions worth $403M, down 1.1% from $407M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 2, leaving the 118-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.
- Boston Research & Management's largest Q1 2025 buy was Tesla: 1,265 shares worth $327K.
- Boston Research & Management added most to NVIDIA in Q1 2025, an estimated $3.56M increase.
- Boston Research & Management's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.09M.
- Boston Research & Management fully exited CVS Health in Q1 2025, selling an estimated $1.52M.
- Boston Research & Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2025.
- Boston Research & Management opened 3 new positions and closed 2 in Q1 2025.
- Boston Research & Management's portfolio value fell 1.1% quarter-over-quarter to $403M.
Based on Boston Research & Management's 13F filing for Q1 2025, filed 12 May 2025.